NDC 63323-821-10
Bortezomib 3.5 mg/1
Bortezomib · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Bortezomib is a injection, powder, lyophilized, for solution containing bortezomib at a strength of 3.5 mg/1. Manufactured by Fresenius Kabi USA, LLC.
Key Facts
- Brand Name
- Bortezomib
- Generic Name
- Bortezomib
- NDC Code (Package)
63323-821-10- NDC Code (Product)
63323-821- Manufacturer
- Fresenius Kabi USA, LLC
- Strength
- 3.5 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- ANDA209659
- Drug Class
- Proteasome Inhibitor [EPC]
- Marketing Start
- 05/02/2022
Recall History
No Recall HistoryView Full Drug Page
Bortezomib — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.